We are so proud to announce that the 2nd Annual Bioprocessing and Biologics Forum will be held on November 27-28, 2024 at (TBA), Amsterdam, Netherlands (Hybrid Event).
Bioprocessing is the development and manufacturing pipeline by which therapeutic agents such as engineered recombinant proteins, viral gene therapy vectors and other nanoparticle-based technologies are produced at levels required for commercial distribution. To achieve this end, large-scale cultures using engineered cell lines are grown in bioreactors or through other scalable approaches. These are constantly being refined and evolved to increase volume, product yield and efficiency. The adoption of next generation bioprocessing is reaching a decisive moment as biopharmaceutical companies are seeking new manufacturing methods that are essential to the industry’s continued growth and innovation. It is more important than ever for the bioprocessing community to connect with one another, share ideas and strategise. Our event will offer unique insights through intensive research with key industry figures, combined with presentations and panel discussions to bring in-depth and informative content.